Wiens James, Hall Brad
Image Plus Laser Eye Centre, Winnipeg, MB, Canada.
Sengi, Penniac, NB, Canada.
Can J Ophthalmol. 2025 Aug;60(4):e536-e540. doi: 10.1016/j.jcjo.2025.01.019. Epub 2025 Mar 3.
To evaluate the visual outcomes and quality of vision in patients receiving a nondiffractive extended depth of focus (EDOF) intraocular lens (IOL), when implanted in eyes with high ocular axial length (≥24.5 mm).
This was a prospective, single-arm, single-surgeon study. Subjects were bilaterally implanted with the Vivity EDOF IOL (toric and nontoric). At 3 months postoperatively, assessments included binocular and monocular visual acuities at distance (6 m), intermediate (66 cm), and near (40 cm), manifest refraction, and administration of a visual disturbance questionnaire (QUVID) and a satisfaction questionnaire (IOLSAT).
At 3 months postoperatively, 100% (20/20), 100% (20/20), and 65% (13/20) of subjects had binocular visual acuity 20/32 or better at distance, intermediate, and near, respectively. Similar visual acuities were obtained with distance correction. At 3 months postoperatively, 93% of eyes (37/40) had manifest refraction spherical equivalent 0.5 D or less. Patient reported spectacle independence was 95% (19/20), 90% (18/20), and 40% (8/20) at distance, intermediate, and near, respectively. Patient-reported satisfaction with their corrected vision was 95% (19/20). In addition, 70% (14/20), 65% (13/20), and 70% (14/20) of subjects reported never or rarely experiencing starburst, halo, and glare, respectively.
The results of this study suggest that the Vivity nontoric and toric IOLs can provide excellent distance and intermediate vision and functional near vision in eyes with high ocular axial length. Good spectacle independence can also be achieved at distance and intermediate, with high reported patient satisfaction and low reported visual disturbances.
评估非衍射性扩展焦深(EDOF)人工晶状体(IOL)植入眼轴长度较高(≥24.5mm)的患者后的视觉效果和视觉质量。
这是一项前瞻性、单臂、单术者研究。受试者双眼植入Vivity EDOF IOL(散光型和非散光型)。术后3个月,评估内容包括远距(6m)、中距(66cm)和近距(40cm)的双眼和单眼视力、显验光、视觉干扰问卷(QUVID)和满意度问卷(IOLSAT)。
术后3个月,分别有100%(20/20)、100%(20/20)和65%(13/20)的受试者在远距、中距和近距的双眼视力达到20/32或更好。通过远距矫正可获得相似的视力。术后3个月,93%的眼(37/40)显验光球镜等效度为0.5D或更低。患者报告在远距、中距和近距分别有95%(19/20)、90%(18/20)和40%(8/20)无需佩戴眼镜。患者报告对矫正视力的满意度为95%(19/20)。此外,分别有70%(14/20)、65%(13/20)和70%(14/20)的受试者报告从未或很少出现星芒、光晕和眩光。
本研究结果表明,Vivity非散光型和散光型IOL可为眼轴长度较高的眼睛提供出色的远距和中距视力以及功能性近视力。在远距和中距也可实现良好的无需佩戴眼镜状态,患者满意度高,视觉干扰报告率低。